Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 187

1.

Any route for melanoblasts to colonize the skin !

Petit V, Larue L.

Exp Dermatol. 2016 Apr 27. doi: 10.1111/exd.13061. [Epub ahead of print]

PMID:
27119971
2.

Regulation of Melanoma Progression Through the TCF4/miR-125b/NEDD9 Cascade.

Rambow F, Bechadergue A, Luciani F, Gros G, Domingues M, Bonaventure J, Meurice G, Marine JC, Larue L.

J Invest Dermatol. 2016 Mar 9. pii: S0022-202X(16)30857-0. doi: 10.1016/j.jid.2016.02.803. [Epub ahead of print]

PMID:
26968260
3.

Meningeal Melanocytes in the Mouse: Distribution and Dependence on Mitf.

Gudjohnsen SA, Atacho DA, Gesbert F, Raposo G, Hurbain I, Larue L, Steingrimsson E, Petersen PH.

Front Neuroanat. 2015 Nov 25;9:149. doi: 10.3389/fnana.2015.00149. eCollection 2015.

4.

New Functional Signatures for Understanding Melanoma Biology from Tumor Cell Lineage-Specific Analysis.

Rambow F, Job B, Petit V, Gesbert F, Delmas V, Seberg H, Meurice G, Van Otterloo E, Dessen P, Robert C, Gautheret D, Cornell RA, Sarasin A, Larue L.

Cell Rep. 2015 Oct 27;13(4):840-53. doi: 10.1016/j.celrep.2015.09.037. Epub 2015 Oct 17.

5.

Deciphering the molecular basis of invasiveness in Sdhb-deficient cells.

Loriot C, Domingues M, Berger A, Menara M, Ruel M, Morin A, Castro-Vega LJ, Letouzé É, Martinelli C, Bemelmans AP, Larue L, Gimenez-Roqueplo AP, Favier J.

Oncotarget. 2015 Oct 20;6(32):32955-65. doi: 10.18632/oncotarget.5106.

6.

Chromatin-Remodelling Complex NURF Is Essential for Differentiation of Adult Melanocyte Stem Cells.

Koludrovic D, Laurette P, Strub T, Keime C, Le Coz M, Coassolo S, Mengus G, Larue L, Davidson I.

PLoS Genet. 2015 Oct 6;11(10):e1005555. doi: 10.1371/journal.pgen.1005555. eCollection 2015 Oct.

7.

What's up NF1?

Grill C, Larue L.

Pigment Cell Melanoma Res. 2016 Jan;29(1):4-5. doi: 10.1111/pcmr.12423. Epub 2015 Nov 3. No abstract available.

PMID:
26394792
8.

A caveolin-dependent and PI3K/AKT-independent role of PTEN in β-catenin transcriptional activity.

Conde-Perez A, Gros G, Longvert C, Pedersen M, Petit V, Aktary Z, Viros A, Gesbert F, Delmas V, Rambow F, Bastian BC, Campbell AD, Colombo S, Puig I, Bellacosa A, Sansom O, Marais R, Van Kempen LC, Larue L.

Nat Commun. 2015 Aug 26;6:8093. doi: 10.1038/ncomms9093.

9.

What is a vertebrate pigment cell?

Schartl M, Larue L, Goda M, Bosenberg MW, Hashimoto H, Kelsh RN.

Pigment Cell Melanoma Res. 2016 Jan;29(1):8-14. doi: 10.1111/pcmr.12409. Epub 2015 Nov 3. Review.

PMID:
26247887
10.

E-cadherin can limit the transforming properties of activating β-catenin mutations.

Huels DJ, Ridgway RA, Radulescu S, Leushacke M, Campbell AD, Biswas S, Leedham S, Serra S, Chetty R, Moreaux G, Parry L, Matthews J, Song F, Hedley A, Kalna G, Ceteci F, Reed KR, Meniel VS, Maguire A, Doyle B, Söderberg O, Barker N, Watson A, Larue L, Clarke AR, Sansom OJ.

EMBO J. 2015 Sep 14;34(18):2321-33. doi: 10.15252/embj.201591739. Epub 2015 Aug 3.

11.

Mitf is a master regulator of the v-ATPase, forming a control module for cellular homeostasis with v-ATPase and TORC1.

Zhang T, Zhou Q, Ogmundsdottir MH, Möller K, Siddaway R, Larue L, Hsing M, Kong SW, Goding CR, Palsson A, Steingrimsson E, Pignoni F.

J Cell Sci. 2015 Aug 1;128(15):2938-50. doi: 10.1242/jcs.173807. Epub 2015 Jun 19.

12.

Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines.

Lazar I, Clement E, Ducoux-Petit M, Denat L, Soldan V, Dauvillier S, Balor S, Burlet-Schiltz O, Larue L, Muller C, Nieto L.

Pigment Cell Melanoma Res. 2015 Jul;28(4):464-75. doi: 10.1111/pcmr.12380. Epub 2015 May 30.

PMID:
25950383
13.

The tyrosine phosphatase SHP2 associates with CUB domain-containing protein-1 (CDCP1), regulating its expression at the cell surface in a phosphorylation-dependent manner.

Gandji LY, Proust R, Larue L, Gesbert F.

PLoS One. 2015 Apr 13;10(4):e0123472. doi: 10.1371/journal.pone.0123472. eCollection 2015.

14.

Altered E-Cadherin Levels and Distribution in Melanocytes Precede Clinical Manifestations of Vitiligo.

Wagner RY, Luciani F, Cario-André M, Rubod A, Petit V, Benzekri L, Ezzedine K, Lepreux S, Steingrimsson E, Taieb A, Gauthier Y, Larue L, Delmas V.

J Invest Dermatol. 2015 Jul;135(7):1810-9. doi: 10.1038/jid.2015.25. Epub 2015 Jan 29.

PMID:
25634357
15.

SQSTM1/p62 regulates the expression of junctional proteins through epithelial-mesenchymal transition factors.

Bertrand M, Petit V, Jain A, Amsellem R, Johansen T, Larue L, Codogno P, Beau I.

Cell Cycle. 2015;14(3):364-74. doi: 10.4161/15384101.2014.987619.

16.

Angiotropism, pericytic mimicry and extravascular migratory metastasis in melanoma: an alternative to intravascular cancer dissemination.

Lugassy C, Zadran S, Bentolila LA, Wadehra M, Prakash R, Carmichael ST, Kleinman HK, Péault B, Larue L, Barnhill RL.

Cancer Microenviron. 2014 Dec;7(3):139-52. doi: 10.1007/s12307-014-0156-4. Epub 2014 Oct 12.

17.

Suppression of autophagy dysregulates the antioxidant response and causes premature senescence of melanocytes.

Zhang CF, Gruber F, Ni C, Mildner M, Koenig U, Karner S, Barresi C, Rossiter H, Narzt MS, Nagelreiter IM, Larue L, Tobin DJ, Eckhart L, Tschachler E.

J Invest Dermatol. 2015 May;135(5):1348-57. doi: 10.1038/jid.2014.439. Epub 2014 Oct 7.

PMID:
25290687
18.

Non-thermal plasmas: novel preventive and curative therapy against melanomas?

Gesbert F, Larue L.

Exp Dermatol. 2014 Oct;23(10):716-7. doi: 10.1111/exd.12481.

PMID:
24980188
19.

miR-330-5p targets tyrosinase and induces depigmentation.

Rambow F, Bechadergue A, Saintigny G, Morizot F, Mahé C, Larue L.

J Invest Dermatol. 2014 Nov;134(11):2846-9. doi: 10.1038/jid.2014.231. Epub 2014 May 26. No abstract available.

20.

Retinoid-X-receptors (α/β) in melanocytes modulate innate immune responses and differentially regulate cell survival following UV irradiation.

Coleman DJ, Garcia G, Hyter S, Jang HS, Chagani S, Liang X, Larue L, Ganguli-Indra G, Indra AK.

PLoS Genet. 2014 May 8;10(5):e1004321. doi: 10.1371/journal.pgen.1004321. eCollection 2014 May.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk